Search
About WifOR
Research
Health
Burden of Disease
Health Economy Reporting
Health ROI Assessor
Social Impact
Sustainability
Economic and R&D Footprint
Environmental Footprint
Impact Valuation
Benchmarks
Value Factors
Scope 3 Assessment
Social Hotspot Analysis
WISIT – the WifOR Institute Sustainability Impact Tool
Labor Market
Big Data Skills Analysis
Employer Attractiveness Analysis
Diversity, Equity & Inclusion
Diversity study
Skilled Labor Analysis
Data packages
GHG Emission Factors
Spend-based Multipliers for Sustainability Analysis
Value Factors
Publications
Newsroom
Career
DE
EN
Contact
Latest publications
Journal publication
Prof. Rifat Atun, Dr. Jan Ludwig Fries, Dr. Karla Hernandez-Villafuerte, Dr. Malina Müller, Prof. Dennis Ostwald, Dr. Maike Schmitt
04/2025
Contribution of investment in health and cancer control to economic growth in Commonwealth countries
Method paper
Prof. Dr. Dennis A. Ostwald, Dr. Malina Müller, Dr. Sandra Zimmermann, Ceyda Ural, Hatice Beton
12/2025
Healthy Returns: A Catalyst for Economic Growth and Resilience
Study
Foteini Tsotra, Prof. Dr. Jos C. van den Berg, Finbar Dolan, Dr. Jasper Ubels, Katrin Ostwald, Lena Steinbeck, Dr. Malina Müller
11/2025
Economic Evaluation of Early Intervention in Chronic Limb Threatening Ischaemia (CLTI)
Library
Research area
Career
Health
Labor Market
Newsletter
Sustainability
Publication type
Conference poster
Journal publication
Method paper
Scientific article
Study
Journal publication
2019
German cost analysis of triplet regimens for relapsed or refractory multiple myeloma patients
Dr. Arpit Misra, Dr. Mathias Kappel, In collaboration with Boris A. Ratsch (Takeda), In collaboration with Edin Basic (Takeda), Janine Pöpper, Prof. Dr. Dennis Ostwald
Study
2019
The Social Impact of Novartis medicines: Two Case Studies from South Africa and Kenya
Ahmed Seddik, Ahmed Seddik, Jennifer Branner, Prof. Dr. Dennis Ostwald, Remon Helmy
Study
2019
The Environmental Impact of Novartis Along Global Supply Chains
Dr. Marcus Cramer, Dr. Richard Scholz, In collaboration with Sonja Haut (Novartis), Natalia Benke, Nora Albu, Prof. Dr. Dennis Ostwald
Journal publication
2019
Cost Effectiveness of Secukinumab Versus Other Biologics and Apremilast in the Treatment of Active Psoriatic Arthritis in Germany
In collaboration with Afschin Gandjour (Frankfurt School of Finance & Management), Prof. Dr. Dennis Ostwald
Journal publication
2019
A case study applying a novel approach to estimate the social impact of a medical innovation – the use of secukinumab for psoriatic arthritis in Germany
Dr. Malina Müller, In collaboration with Bintu Sherif (RTI HS), Prof. Dr. Dennis Ostwald, Sebastian Himmler
Conference poster
2018
The Societal Impact of Obinutuzumab in the First Line Treatment of Patients with Follicular Lymphoma in Germany
Sarah Hofmann, Sebastian Himmler, Prof. Dr. Dennis Ostwald, Ulrich Dünziger, Aino Launonen, Helena Salmen
‹
1
…
15
16
17
18
19
›
Interested in our newsletter?
Register
